Approval Year
Substance Class |
Nucleic Acid
Created
by
admin
on
Edited
Sat Dec 16 09:13:16 GMT 2023
by
admin
on
Sat Dec 16 09:13:16 GMT 2023
|
Nucleic Acid Subtype | |
Sequence Type | COMPLETE |
Record UNII |
5Z9SP3X666
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000191626
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
||
|
FDA ORPHAN DRUG |
336711
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
||
|
WHO-ATC |
M09AX07
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
||
|
NDF-RT |
N0000193222
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5207
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
m11974
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
10003
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
CHEMBL3301572
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
1863556
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
NUSINERSEN
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
AB-110
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
5Z9SP3X666
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
5Z9SP3X666
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
C166875
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
SUB182823
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
DTXSID301027785
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
DB13161
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY | |||
|
1258984-36-9
Created by
admin on Sat Dec 16 09:13:16 GMT 2023 , Edited by admin on Sat Dec 16 09:13:16 GMT 2023
|
PRIMARY |
Sugar | Site Range | Site Count |
---|---|---|
2-O-beta-hydroxy-ethoxy-methyl Ribose (Qiagen) | 1_1-1_18 | 18 / 18 |
Linkage | Site Range | Site Count |
---|---|---|
Phosporothioate | 1_2-1_18 | 17 / 17 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Structural Modifications
Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
---|---|---|---|---|---|---|
BASE SUBSTITUTION | [1_2] [1_4] [1_8] [1_15] | CYTOSINE | 5-METHYLCYTOSINE | 6R795CQT4H |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER | CHEMICAL |
|